vs
Circle Internet Group, Inc.（CRCL）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
Circle Internet Group, Inc.的季度营收约是ICU MEDICAL INC的1.4倍（$739.8M vs $540.7M），Circle Internet Group, Inc.净利率更高（29.0% vs -2.9%，领先31.9%），Circle Internet Group, Inc.同比增速更快（5113.5% vs -14.1%），ICU MEDICAL INC自由现金流更多（$36.0M vs $-14.7M）
Circle是2013年由杰里米·阿莱尔与肖恩·内维尔联合创立的支付科技企业，目前总部位于美国纽约，核心业务覆盖稳定币发行，推出了锚定美元的USDC、锚定欧元的EURC两款稳定币，同时还发行有代币化货币市场基金产品USYC。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
CRCL vs ICUI — 直观对比
营收规模更大
CRCL
是对方的1.4倍
$540.7M
营收增速更快
CRCL
高出5127.7%
-14.1%
净利率更高
CRCL
高出31.9%
-2.9%
自由现金流更多
ICUI
多$50.7M
$-14.7M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $739.8M | $540.7M |
| 净利润 | $214.4M | $-15.7M |
| 毛利率 | — | 37.5% |
| 营业利润率 | 11.0% | 1.0% |
| 净利率 | 29.0% | -2.9% |
| 营收同比 | 5113.5% | -14.1% |
| 净利润同比 | 202.0% | 34.0% |
| 每股收益（稀释后） | $0.64 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRCLICUI
| Q4 25 | — | $540.7M | ||
| Q3 25 | $739.8M | $537.0M | ||
| Q2 25 | $658.1M | $548.9M | ||
| Q1 25 | — | $604.7M | ||
| Q4 24 | — | $629.8M | ||
| Q3 24 | — | $589.1M | ||
| Q2 24 | $6.8M | $596.5M | ||
| Q1 24 | — | $566.7M |
净利润CRCLICUI
| Q4 25 | — | $-15.7M | ||
| Q3 25 | $214.4M | $-3.4M | ||
| Q2 25 | $-482.1M | $35.3M | ||
| Q1 25 | — | $-15.5M | ||
| Q4 24 | — | $-23.8M | ||
| Q3 24 | — | $-33.0M | ||
| Q2 24 | $32.9M | $-21.4M | ||
| Q1 24 | — | $-39.5M |
毛利率CRCLICUI
| Q4 25 | — | 37.5% | ||
| Q3 25 | — | 37.4% | ||
| Q2 25 | — | 37.9% | ||
| Q1 25 | — | 34.7% | ||
| Q4 24 | — | 36.1% | ||
| Q3 24 | — | 34.8% | ||
| Q2 24 | — | 34.8% | ||
| Q1 24 | — | 32.7% |
营业利润率CRCLICUI
| Q4 25 | — | 1.0% | ||
| Q3 25 | 11.0% | 2.6% | ||
| Q2 25 | -49.5% | 1.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | -1.9% |
净利率CRCLICUI
| Q4 25 | — | -2.9% | ||
| Q3 25 | 29.0% | -0.6% | ||
| Q2 25 | -73.3% | 6.4% | ||
| Q1 25 | — | -2.6% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | — | -5.6% | ||
| Q2 24 | 486.5% | -3.6% | ||
| Q1 24 | — | -7.0% |
每股收益（稀释后）CRCLICUI
| Q4 25 | — | $-0.63 | ||
| Q3 25 | $0.64 | $-0.14 | ||
| Q2 25 | $-4.48 | $1.43 | ||
| Q1 25 | — | $-0.63 | ||
| Q4 24 | — | $-0.97 | ||
| Q3 24 | — | $-1.35 | ||
| Q2 24 | $0.00 | $-0.88 | ||
| Q1 24 | — | $-1.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.3B | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.0B | $2.1B |
| 总资产 | $76.8B | $4.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CRCLICUI
| Q4 25 | — | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $308.6M | ||
| Q3 24 | — | $312.5M | ||
| Q2 24 | $457.5M | $302.6M | ||
| Q1 24 | — | $251.4M |
股东权益CRCLICUI
| Q4 25 | — | $2.1B | ||
| Q3 25 | $3.0B | $2.1B | ||
| Q2 25 | $2.4B | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | $460.9M | $2.0B | ||
| Q1 24 | — | $2.1B |
总资产CRCLICUI
| Q4 25 | — | $4.1B | ||
| Q3 25 | $76.8B | $4.1B | ||
| Q2 25 | $64.2B | $4.1B | ||
| Q1 25 | — | $4.2B | ||
| Q4 24 | — | $4.2B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $4.3B | ||
| Q1 24 | — | $4.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.7M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | $-14.7M | $36.0M |
| 自由现金流率自由现金流/营收 | -2.0% | 6.6% |
| 资本支出强度资本支出/营收 | 0.5% | 4.6% |
| 现金转化率经营现金流/净利润 | -0.05× | — |
| 过去12个月自由现金流最近4个季度 | — | $91.8M |
8季度趋势，按日历期对齐
经营现金流CRCLICUI
| Q4 25 | — | $60.6M | ||
| Q3 25 | $-10.7M | $56.7M | ||
| Q2 25 | $303.7M | $11.2M | ||
| Q1 25 | — | $51.3M | ||
| Q4 24 | — | $40.2M | ||
| Q3 24 | — | $36.1M | ||
| Q2 24 | — | $82.0M | ||
| Q1 24 | — | $45.8M |
自由现金流CRCLICUI
| Q4 25 | — | $36.0M | ||
| Q3 25 | $-14.7M | $27.6M | ||
| Q2 25 | $296.3M | $-8.5M | ||
| Q1 25 | — | $36.7M | ||
| Q4 24 | — | $16.1M | ||
| Q3 24 | — | $16.2M | ||
| Q2 24 | — | $62.5M | ||
| Q1 24 | — | $29.9M |
自由现金流率CRCLICUI
| Q4 25 | — | 6.6% | ||
| Q3 25 | -2.0% | 5.1% | ||
| Q2 25 | 45.0% | -1.5% | ||
| Q1 25 | — | 6.1% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 10.5% | ||
| Q1 24 | — | 5.3% |
资本支出强度CRCLICUI
| Q4 25 | — | 4.6% | ||
| Q3 25 | 0.5% | 5.4% | ||
| Q2 25 | 1.1% | 3.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | 2.8% |
现金转化率CRCLICUI
| Q4 25 | — | — | ||
| Q3 25 | -0.05× | — | ||
| Q2 25 | — | 0.32× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRCL
暂无分部数据
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
